Stockreport

Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study [Yahoo! Finance]

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF candidate, relacorilant, for treating patients with all etiologies of endogenous Cushing's syndrome. The GRACE study consists of two parts. The above mentioned data wa [Read more]